905 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 19 | next »
Genei
Gene descriptioni x
Evidencei x
Tissuei
Braini
Single celli
Subcelli
Canceri
Bloodi
Cell linei
Struct & Inti
Prognostic p-valuei x
PRIM2DNA primase subunit 2
Kidney Chromophobe (TCGA): 1.03e-7
Liver Hepatocellular Carcinoma (TCGA): 5.35e-6
Liver Hepatocellular Carcinoma (validation): 5.51e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.03e-4
Rectum Adenocarcinoma (TCGA): 7.99e-4
TOP2ADNA topoisomerase II alpha
Kidney Renal Clear Cell Carcinoma (TCGA): 3.39e-11
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.59e-8
Liver Hepatocellular Carcinoma (validation): 1.38e-7
Kidney Chromophobe (TCGA): 3.04e-7
Kidney Renal Clear Cell Carcinoma (validation): 1.07e-5
Lung Adenocarcinoma (TCGA): 2.63e-5
Liver Hepatocellular Carcinoma (TCGA): 5.06e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.81e-4
ASF1BAnti-silencing function 1B histone chaperone
Liver Hepatocellular Carcinoma (validation): 1.21e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.29e-9
Kidney Chromophobe (TCGA): 8.56e-7
Kidney Renal Clear Cell Carcinoma (validation): 1.59e-6
Pancreatic Adenocarcinoma (TCGA): 1.09e-5
Lung Adenocarcinoma (validation): 3.22e-5
Lung Adenocarcinoma (TCGA): 1.50e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.57e-4
Stomach Adenocarcinoma (TCGA): 4.66e-4
Liver Hepatocellular Carcinoma (TCGA): 5.76e-4
Lung Squamous Cell Carcinoma (TCGA): 9.62e-4
E2F1E2F transcription factor 1
Liver Hepatocellular Carcinoma (validation): 6.43e-7
Kidney Chromophobe (TCGA): 1.15e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.52e-5
Pancreatic Adenocarcinoma (TCGA): 3.91e-5
Liver Hepatocellular Carcinoma (TCGA): 1.10e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.49e-4
CDK4Cyclin dependent kinase 4
Liver Hepatocellular Carcinoma (validation): 6.92e-9
Liver Hepatocellular Carcinoma (TCGA): 2.03e-6
Kidney Chromophobe (TCGA): 2.54e-6
Lung Adenocarcinoma (validation): 7.99e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 8.59e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.14e-4
PSME3Proteasome activator subunit 3
Kidney Chromophobe (TCGA): 2.94e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.20e-5
Lung Adenocarcinoma (TCGA): 1.10e-4
Liver Hepatocellular Carcinoma (validation): 3.03e-4
Liver Hepatocellular Carcinoma (TCGA): 4.69e-4
COPS6COP9 signalosome subunit 6
Liver Hepatocellular Carcinoma (validation): 9.43e-7
Kidney Chromophobe (TCGA): 3.41e-6
Liver Hepatocellular Carcinoma (TCGA): 3.95e-5
Lung Adenocarcinoma (TCGA): 4.28e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.92e-4
AURKBAurora kinase B
Kidney Renal Clear Cell Carcinoma (TCGA): 6.48e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.75e-9
Liver Hepatocellular Carcinoma (validation): 1.76e-8
Kidney Chromophobe (TCGA): 3.78e-6
Liver Hepatocellular Carcinoma (TCGA): 5.19e-5
Lung Adenocarcinoma (TCGA): 1.57e-4
Kidney Renal Clear Cell Carcinoma (validation): 5.06e-4
MYBL2MYB proto-oncogene like 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.66e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.90e-9
Liver Hepatocellular Carcinoma (TCGA): 1.16e-8
Liver Hepatocellular Carcinoma (validation): 1.27e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.73e-6
Kidney Chromophobe (TCGA): 3.85e-6
Lung Adenocarcinoma (TCGA): 1.43e-5
Lung Adenocarcinoma (validation): 8.96e-4
CDKN3Cyclin dependent kinase inhibitor 3
Liver Hepatocellular Carcinoma (validation): 5.00e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.30e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.38e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 9.21e-7
Lung Adenocarcinoma (TCGA): 3.93e-6
Kidney Chromophobe (TCGA): 4.42e-6
Ovary Serous Cystadenocarcinoma (validation): 8.24e-5
Pancreatic Adenocarcinoma (TCGA): 6.57e-4
Liver Hepatocellular Carcinoma (TCGA): 7.07e-4
POC1APOC1 centriolar protein A
Liver Hepatocellular Carcinoma (validation): 2.68e-6
Kidney Chromophobe (TCGA): 4.42e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 5.24e-5
Lung Adenocarcinoma (TCGA): 9.28e-5
Liver Hepatocellular Carcinoma (TCGA): 9.43e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.25e-4
Lung Adenocarcinoma (validation): 5.27e-4
MRPL47Mitochondrial ribosomal protein L47
Kidney Chromophobe (TCGA): 4.81e-6
Lung Adenocarcinoma (TCGA): 4.84e-5
Liver Hepatocellular Carcinoma (TCGA): 1.07e-4
Liver Hepatocellular Carcinoma (validation): 1.99e-4
Lung Adenocarcinoma (validation): 2.05e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.53e-4
RPUSD3RNA pseudouridine synthase D3
Kidney Chromophobe (TCGA): 5.09e-6
Liver Hepatocellular Carcinoma (TCGA): 5.63e-6
Liver Hepatocellular Carcinoma (validation): 3.10e-4
Glioblastoma Multiforme (validation): 3.19e-4
METTL6Methyltransferase 6, methylcytidine
Liver Hepatocellular Carcinoma (TCGA): 3.13e-7
Kidney Chromophobe (TCGA): 9.27e-6
Rectum Adenocarcinoma (TCGA): 1.43e-4
Liver Hepatocellular Carcinoma (validation): 5.36e-4
Ovary Serous Cystadenocarcinoma (validation): 5.92e-4
ENO1Enolase 1
Liver Hepatocellular Carcinoma (validation): 1.58e-8
Liver Hepatocellular Carcinoma (TCGA): 1.82e-7
Kidney Chromophobe (TCGA): 1.01e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.88e-5
Bladder Urothelial Carcinoma (TCGA): 3.82e-5
Glioblastoma Multiforme (TCGA): 4.24e-5
Lung Adenocarcinoma (TCGA): 4.90e-5
Lung Adenocarcinoma (validation): 8.94e-4
P2RY8P2Y receptor family member 8
Kidney Renal Clear Cell Carcinoma (TCGA): 3.06e-10
Kidney Chromophobe (TCGA): 1.08e-5
Lung Adenocarcinoma (TCGA): 8.61e-5
Liver Hepatocellular Carcinoma (TCGA): 1.41e-4
Kidney Renal Clear Cell Carcinoma (validation): 1.53e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 2.22e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 8.16e-4
CENPFCentromere protein F
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.49e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.58e-7
Lung Adenocarcinoma (TCGA): 3.18e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 3.33e-6
Liver Hepatocellular Carcinoma (validation): 6.56e-6
Kidney Chromophobe (TCGA): 1.17e-5
Liver Hepatocellular Carcinoma (TCGA): 2.64e-5
Pancreatic Adenocarcinoma (TCGA): 4.13e-4
FANCIFA complementation group I
Kidney Chromophobe (TCGA): 1.59e-5
Liver Hepatocellular Carcinoma (TCGA): 4.13e-5
Liver Hepatocellular Carcinoma (validation): 8.37e-5
Glioblastoma Multiforme (validation): 2.36e-4
Lung Adenocarcinoma (validation): 9.99e-4
BRK1BRICK1 subunit of SCAR/WAVE actin nucleating complex
Liver Hepatocellular Carcinoma (validation): 1.39e-8
Liver Hepatocellular Carcinoma (TCGA): 3.02e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 5.59e-6
Kidney Chromophobe (TCGA): 1.89e-5
Kidney Renal Clear Cell Carcinoma (validation): 3.62e-4
FAM83DFamily with sequence similarity 83 member D
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.04e-11
Liver Hepatocellular Carcinoma (validation): 6.14e-7
Lung Adenocarcinoma (TCGA): 9.46e-6
Kidney Chromophobe (TCGA): 2.14e-5
Liver Hepatocellular Carcinoma (TCGA): 3.42e-5
Pancreatic Adenocarcinoma (TCGA): 3.68e-5
Lung Adenocarcinoma (validation): 5.02e-4
RBMXL1RBMX like 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.71e-7
Kidney Chromophobe (TCGA): 2.41e-5
Pancreatic Adenocarcinoma (TCGA): 8.48e-5
Kidney Renal Clear Cell Carcinoma (validation): 6.21e-4
FNDC3BFibronectin type III domain containing 3B
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 5.69e-7
Kidney Chromophobe (TCGA): 2.71e-5
Ovary Serous Cystadenocarcinoma (validation): 2.35e-4
Pancreatic Adenocarcinoma (validation): 5.16e-4
Liver Hepatocellular Carcinoma (validation): 5.27e-4
Pancreatic Adenocarcinoma (TCGA): 6.79e-4
SEC24BSEC24 homolog B, COPII coat complex component
Kidney Renal Clear Cell Carcinoma (TCGA): 4.38e-8
Kidney Renal Clear Cell Carcinoma (validation): 6.08e-6
Kidney Chromophobe (TCGA): 2.74e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 2.92e-4
Liver Hepatocellular Carcinoma (validation): 4.16e-4
Breast Invasive Carcinoma (TCGA): 4.21e-4
Lung Adenocarcinoma (validation): 7.61e-4
PDCD10Programmed cell death 10
Kidney Renal Clear Cell Carcinoma (TCGA): 3.80e-6
Kidney Chromophobe (TCGA): 3.44e-5
Liver Hepatocellular Carcinoma (TCGA): 3.66e-4
Liver Hepatocellular Carcinoma (validation): 4.33e-4
Pancreatic Adenocarcinoma (TCGA): 9.39e-4
ZNF207Zinc finger protein 207
Kidney Renal Clear Cell Carcinoma (TCGA): 7.11e-7
Liver Hepatocellular Carcinoma (TCGA): 1.25e-5
Kidney Chromophobe (TCGA): 3.48e-5
Colon Adenocarcinoma (TCGA): 6.06e-5
Liver Hepatocellular Carcinoma (validation): 1.25e-4
Lung Adenocarcinoma (TCGA): 3.63e-4
CCNB2Cyclin B2
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.05e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 3.29e-9
Liver Hepatocellular Carcinoma (validation): 4.73e-8
Lung Adenocarcinoma (TCGA): 1.07e-5
Liver Hepatocellular Carcinoma (TCGA): 1.31e-5
Pancreatic Adenocarcinoma (TCGA): 2.47e-5
Kidney Chromophobe (TCGA): 4.17e-5
Kidney Renal Clear Cell Carcinoma (validation): 4.36e-5
Lung Adenocarcinoma (validation): 2.43e-4
USP33Ubiquitin specific peptidase 33
Kidney Chromophobe (TCGA): 4.65e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 5.48e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.78e-4
KIF20AKinesin family member 20A
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.32e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 1.12e-11
Liver Hepatocellular Carcinoma (TCGA): 4.68e-9
Liver Hepatocellular Carcinoma (validation): 5.05e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.58e-6
Pancreatic Adenocarcinoma (TCGA): 7.84e-6
Lung Adenocarcinoma (TCGA): 7.90e-6
Lung Adenocarcinoma (validation): 1.36e-5
Kidney Chromophobe (TCGA): 4.65e-5
HDAC2Histone deacetylase 2
Liver Hepatocellular Carcinoma (TCGA): 7.54e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 5.89e-6
Liver Hepatocellular Carcinoma (validation): 2.65e-5
Kidney Chromophobe (TCGA): 4.74e-5
Breast Invasive Carcinoma (TCGA): 2.16e-4
FAM135AFamily with sequence similarity 135 member A
Kidney Renal Clear Cell Carcinoma (TCGA): 1.59e-5
Kidney Chromophobe (TCGA): 4.86e-5
Kidney Renal Clear Cell Carcinoma (validation): 7.37e-4
ATG7Autophagy related 7
Kidney Renal Clear Cell Carcinoma (TCGA): 1.69e-5
Kidney Chromophobe (TCGA): 5.02e-5
Liver Hepatocellular Carcinoma (TCGA): 6.99e-5
Ovary Serous Cystadenocarcinoma (TCGA): 7.44e-4
Liver Hepatocellular Carcinoma (validation): 7.44e-4
POLD2DNA polymerase delta 2, accessory subunit
Liver Hepatocellular Carcinoma (validation): 4.99e-6
Liver Hepatocellular Carcinoma (TCGA): 7.13e-6
Lung Adenocarcinoma (TCGA): 1.06e-5
Kidney Chromophobe (TCGA): 5.59e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 2.31e-4
Lung Adenocarcinoma (validation): 6.24e-4
EIF2B1Eukaryotic translation initiation factor 2B subunit alpha
Liver Hepatocellular Carcinoma (TCGA): 3.05e-9
Liver Hepatocellular Carcinoma (validation): 4.04e-5
Kidney Chromophobe (TCGA): 5.69e-5
Lung Adenocarcinoma (validation): 6.80e-5
PRR11Proline rich 11
Liver Hepatocellular Carcinoma (validation): 1.40e-8
Liver Hepatocellular Carcinoma (TCGA): 1.01e-6
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.24e-6
Lung Adenocarcinoma (TCGA): 4.72e-6
Kidney Chromophobe (TCGA): 5.78e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.61e-4
Lung Adenocarcinoma (validation): 6.87e-4
SLAIN2SLAIN motif family member 2
Kidney Renal Clear Cell Carcinoma (TCGA): 9.43e-8
Kidney Chromophobe (TCGA): 6.06e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.20e-4
PSMD11Proteasome 26S subunit, non-ATPase 11
Liver Hepatocellular Carcinoma (validation): 1.84e-5
Lung Adenocarcinoma (TCGA): 2.36e-5
Kidney Chromophobe (TCGA): 6.35e-5
Liver Hepatocellular Carcinoma (TCGA): 1.19e-4
Colon Adenocarcinoma (validation): 8.75e-4
POP7POP7 homolog, ribonuclease P/MRP subunit
Liver Hepatocellular Carcinoma (TCGA): 1.69e-8
Kidney Renal Clear Cell Carcinoma (TCGA): 8.88e-8
Liver Hepatocellular Carcinoma (validation): 6.79e-5
Kidney Chromophobe (TCGA): 6.79e-5
AIMP2Aminoacyl tRNA synthetase complex interacting multifunctional protein 2
Kidney Chromophobe (TCGA): 7.35e-5
Breast Invasive Carcinoma (TCGA): 8.20e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 9.92e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 3.74e-4
Lung Adenocarcinoma (validation): 6.73e-4
Colon Adenocarcinoma (TCGA): 6.75e-4
Lung Adenocarcinoma (TCGA): 7.91e-4
TBRG4Transforming growth factor beta regulator 4
Liver Hepatocellular Carcinoma (validation): 1.95e-6
Kidney Chromophobe (TCGA): 7.55e-5
Lung Adenocarcinoma (TCGA): 8.13e-5
Liver Hepatocellular Carcinoma (TCGA): 2.86e-4
ZNF709Zinc finger protein 709
Kidney Renal Clear Cell Carcinoma (TCGA): 8.98e-6
Kidney Chromophobe (TCGA): 7.66e-5
Kidney Renal Clear Cell Carcinoma (validation): 6.93e-4
NECAP1NECAP endocytosis associated 1
Kidney Renal Clear Cell Carcinoma (TCGA): 7.56e-8
Kidney Chromophobe (TCGA): 7.90e-5
Breast Invasive Carcinoma (TCGA): 1.36e-4
Kidney Renal Clear Cell Carcinoma (validation): 4.33e-4
Colon Adenocarcinoma (validation): 4.96e-4
ZCRB1Zinc finger CCHC-type and RNA binding motif containing 1
Liver Hepatocellular Carcinoma (TCGA): 1.37e-9
Kidney Chromophobe (TCGA): 8.09e-5
Liver Hepatocellular Carcinoma (validation): 1.94e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.38e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 6.45e-4
TMEM233Transmembrane protein 233
Kidney Renal Clear Cell Carcinoma (validation): 1.32e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 4.50e-5
Kidney Chromophobe (TCGA): 8.27e-5
NOP16NOP16 nucleolar protein
Kidney Chromophobe (TCGA): 9.23e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.59e-4
Liver Hepatocellular Carcinoma (validation): 2.13e-4
Prostate Adenocarcinoma (TCGA): 2.56e-4
Liver Hepatocellular Carcinoma (TCGA): 4.16e-4
Lung Adenocarcinoma (validation): 7.50e-4
Lung Adenocarcinoma (TCGA): 7.89e-4
CRCPCGRP receptor component
Kidney Renal Clear Cell Carcinoma (TCGA): 9.49e-10
Kidney Chromophobe (TCGA): 9.72e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.53e-4
GNB1G protein subunit beta 1
Kidney Renal Clear Cell Carcinoma (TCGA): 4.40e-6
Liver Hepatocellular Carcinoma (validation): 1.54e-5
Kidney Chromophobe (TCGA): 9.94e-5
Liver Hepatocellular Carcinoma (TCGA): 1.84e-4
EZH2Enhancer of zeste 2 polycomb repressive complex 2 subunit
Liver Hepatocellular Carcinoma (TCGA): 1.87e-7
Liver Hepatocellular Carcinoma (validation): 2.24e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.34e-5
Kidney Chromophobe (TCGA): 1.07e-4
Pancreatic Adenocarcinoma (TCGA): 2.76e-4
FAAP24FA core complex associated protein 24
Kidney Renal Clear Cell Carcinoma (TCGA): 3.28e-9
Kidney Chromophobe (TCGA): 1.07e-4
Kidney Renal Clear Cell Carcinoma (validation): 1.67e-4
RACGAP1Rac GTPase activating protein 1
Liver Hepatocellular Carcinoma (validation): 1.86e-7
Lung Adenocarcinoma (TCGA): 2.70e-6
Liver Hepatocellular Carcinoma (TCGA): 3.21e-6
Lung Adenocarcinoma (validation): 3.44e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.51e-5
Kidney Chromophobe (TCGA): 1.10e-4
Pancreatic Adenocarcinoma (TCGA): 1.29e-4
Kidney Renal Clear Cell Carcinoma (validation): 5.95e-4
Breast Invasive Carcinoma (TCGA): 9.25e-4
Page of 19 | next »